RecruitingNCT04763343
Ketamine or placebo with suicide-focused therapy for young people
About this title
Read the official source — NCT04763343Medication studyAges 14–30United StatesSuicide prevention
Understand this study
Who could participate?
Listed age limits: 14 years to 30 years.
- Listed locations
- ClevelandSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 27, 2022
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 60
- Sponsor
- Tatiana Falcone, MD
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 14 Years to 30 Years
- Official registry ID
- NCT04763343
- Official title
Show the full official title
Ketamine Treatment of Youth Suicide Attempters for Fast Reduction of Severe Suicide Risk and Facilitation of Long-term Collaborative Clinical Engagement: A Double Blind Randomized Placebo Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Cleveland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Tatiana Falcone, MD.
Does this study involve medication?
Yes. The study involves medication, including Ketamine Hydrochloride and Saline.
Who can participate?
Listed age limits: 14 years to 30 years.
Is this study still recruiting?
The registry lists this study as recruiting.
